Fustibal Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Fustibal General Information
Description
Operator of a biotechnology company intended to develop antibody-based nanomedicines for multi-targeted cancer therapy. The company offers a drug-targeting platform, modular targeted therapeutics, and a companion diagnostic platform, enabling pharmaceutical companies the develop chemical and biological products to fight cancer.
Contact Information
Website
www.fustibal.comCorporate Office
- 1700 4th Street
- Suite 214
- San Francisco, CA 94143
- United States
Corporate Office
- 1700 4th Street
- Suite 214
- San Francisco, CA 94143
- United States
Fustibal Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Fustibal Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Fustibal Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| QB3 | Accelerator/Incubator |
Fustibal FAQs
-
When was Fustibal founded?
Fustibal was founded in 2014.
-
Where is Fustibal headquartered?
Fustibal is headquartered in San Francisco, CA.
-
What industry is Fustibal in?
Fustibal’s primary industry is Biotechnology.
-
Is Fustibal a private or public company?
Fustibal is a Private company.
-
What is Fustibal’s current revenue?
The current revenue for Fustibal is .
-
Who are Fustibal’s investors?
QB3 has invested in Fustibal.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
